title: The IL-8, VEGF, and CFH polymorphisms and bevacizumab in age-related macular degeneration.
authors.affiliation: Department of Ophthalmology, Helsinki University Central Hospital, Finland.
authors.forename: Asta
authors.initials: A
authors.lastname: Hautamäki
authors.affiliation: Department of Medical Genetics, University of Helsinki, Finland.
authors.forename: Jarno
authors.initials: J
authors.lastname: Kivioja
authors.affiliation: Department of Ophthalmology, Helsinki University Central Hospital, Finland.
authors.forename: Sanna
authors.initials: S
authors.lastname: Seitsonen
authors.affiliation: NordLab Oulu, Oulu University Hospital, and Department of Clinical Chemistry, University of Oulu, Finland.
authors.forename: Eeva-Riitta
authors.initials: ER
authors.lastname: Savolainen
authors.affiliation: Department of Ophthalmology, Institute of Clinical Medicine, and Department of Internal Medicine, Oulu University Hospital, Clinical Research Center and Biocenter Oulu, University of Oulu, Finland.
authors.forename: M Johanna
authors.initials: MJ
authors.lastname: Liinamaa
authors.affiliation: Department of Mathematics and Statistics, University of Tampere, Finland.
authors.forename: Arto
authors.initials: A
authors.lastname: Luoma
authors.affiliation: Department of Medical Genetics, University of Helsinki, Finland.
authors.forename: Irma
authors.initials: I
authors.lastname: Järvelä
authors.affiliation: Department of Ophthalmology, Helsinki University Central Hospital, Finland.
authors.forename: Ilkka
authors.initials: I
authors.lastname: Immonen
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D004396:Coloring Agents; D017242:Complement Factor H / Q000235:genetics; D005260:Female; D005451:Fluorescein Angiography; D005838:Genotype; D006801:Humans; D007208:Indocyanine Green; D016209:Interleukin-8 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*; D014792:Visual Acuity; D057135:Wet Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C493495:CFH protein, human; C508606:CXCL8 protein, human; D004396:Coloring Agents; D016209:Interleukin-8; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D017242:Complement Factor H; D007208:Indocyanine Green